Goals
We focus on a well-defined, limited set of conditions: Parkinson’s disease; atypical parkinsonism; rare hereditary movement disorders, in particular cerebellar ataxia and hereditary spastic paraplegia; tremors; and gait and balance disorders. Our goals are:
- Identify pathways for primary, secondary and tertiary prevention.
- Based on these insights: develop and evaluate disease-modifying interventions.
- Study novel symptomatic therapies (both pharmacological as and non-pharmacological).
- Develop novel diagnostic and progression biomarkers, including digital, neurochemical and neuroimaging techniques.